Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system-Reference-Cited by-同舟云学术

Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system

Published:2022 Issue: Volume:31 Page:100534
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Perdrizet Kirstin^ORCID,Stockley Tracy L.,Law Jennifer H.,Smith Adam,Zhang Tong,Fernandes Roxanne,Shabir Muqdas,Sabatini Peter,Youssef Nadia Al,Ishu Christine,Li Janice JN,Tsao Ming-Sound,Pal Prodipto,Cabanero Michael,Schwock Joerg,Ko Hyang Mi,Boerner Scott,Ruff Heather,Shepherd Frances A.,Bradbury Penelope A.,Liu Geoffrey,Sacher Adrian G.,Leighl Natasha B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Overall survival with Osimertinib in untreated, EGFR-mutated advanced NSCLC;Ramalingam;N. Engl. J. Med.,2020

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N. Engl. J. Med.,2009

3. Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non-small-cell lung cancer;Solomon;J. Clin. Oncol.,2018

4. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the college of american pathologists, the international association for the study of lung cancer, and the;Lindeman;J. Thorac. Oncol.,2018

5. National comprehensive cancer network clinical practice guideline: non-small cell lung cancer;Version 7,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre;ESMO Open;2023-12

2. Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases;Translational Lung Cancer Research;2023-11

3. Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer;Current Oncology;2022-07-15

4. Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer;Current Oncology;2022-06-22

5. An Idealized Clinicogenomic Registry to Engage Underrepresented Populations Using Innovative Technology;Journal of Personalized Medicine;2022-04-29